Page results
-
The aim of this page is to provide you with information about flow-diverting stents and how they are used to treat cerebral (brain) aneurysms.
-
Professor Manjit Matharu's major research interests include migraine, trigeminal autonomic cephalalgias, facial pain, neurostimulation for intractable headaches, spontaneous intracranial hypotension and other headache disorders in hypermobility syndromes.
-
More people with dementia in the UK will be able to take part in research and help accelerate the development of new treatments, as the Government announces £49.9 million of new funding to build a network of dementia trials sites across the country.
-
T16 North is a specialist adult haematology inpatient ward dedicated to providing high-quality care for patients with a wide range of blood disorders.
-
The iconic run has returned to its regular time of the year, following two years’ disruption following the pandemic and will take place on Sunday 2 October 2022. We are lucky enough to have five people running for UCLH Charity. The money they raise will help us support patients, staff and research at UCLH.
-
A second mass vaccination event will be held over four days this month at Emirates Stadium in a bid to give thousands more people the chance to have their first or second dose of the Pfizer Covid-19 vaccine.
-
John McGrath is a newly appointed governor as a stakeholder member from North Central London Clinical Commissioning Group (CCG). He is a local GP and has lived and worked in Islington for the last decade in a number of different settings, including multiple GP surgeries as a salaried doctor, local A&E departments and urgent care.
-
Information on contrast agents for X-ray, fluoroscopy, CT and angiography examinations at NHNN
-
Two UCLH nurses who have dedicated their entire career to the NHS were invited to attend a VE Day celebration concert last Thursday.
-
Today is International Clinical Trials Day, an important day on the UCLH calendar because research is an integral part of UCLH’s mission.
File results
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0336 - Number of pagers currently in use at the Trust
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0337 - Trac systems e-recruitment software used at the Trust
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0330 - Outsourced/ in-house occupational health provisions